Hexagon Nutrition listing on the NSE

Hexagon Nutrition shares rallied sharply on their stock market debut on Friday, ending at the upper circuit after listing at a premium of around 7 per cent over the issue price.

The stock debuted at ₹48 on the BSE, a premium of 6.66 per cent to its issue price of ₹45 per share. On the NSE, the stock listed at ₹48.25, reflecting a premium of 7.2 per cent.

Following the listing, buying interest gathered momentum, pushing the stock to its upper circuit limits of ₹50.66 on the NSE and ₹50.39 on the BSE. At these levels, the stock closed about 12-12.5 per cent above its offer price.

Dr Ravi Singh, Chief Research Officer at Master Capital Services, highlighted the company’s leadership in premixes and micronutrient products, along with its portfolio of nutrition brands and supply relationships with FMCG companies and UN programmes.

Singh maintained a positive long-term outlook on the stock, though he cautioned that near-term sentiment could remain subdued. He advised long-term investors to consider the stock, while conservative investors may wait for price stability.

IPO’s strong demand

The positive listing came after the company’s ₹139-crore initial public offering (IPO) witnessed strong investor demand. The issue was subscribed 53.68 times overall during the bidding process.

The non-institutional investor category saw the strongest response, garnering subscription of 161.49 times. The retail investor portion was subscribed 26.85 times, while the quota reserved for qualified institutional buyers (QIBs) was booked 19.77 times.

Ahead of the IPO, Hexagon Nutrition raised ₹41.66 crore from anchor investors. The price band for the public issue was fixed at ₹42-45 per equity share.

The IPO consisted entirely of an offer-for-sale (OFS) of more than 3.08 crore equity shares by the company’s promoters. As a result, the company did not receive any proceeds from the issue.

Hexagon Nutrition said the proposed listing was aimed at enhancing its visibility, strengthening brand recognition and providing liquidity to existing shareholders.

Founded in 1993, the company began operations as a micronutrient formulations business and subsequently diversified into branded nutrition products. Its portfolio includes brands such as Pentasure, Obesigo and Pediagold, catering to health, wellness and clinical nutrition segments.

More Like This

Published on June 12, 2026